Full-Time

Brand Insights and Analytics Lead

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

Compensation Overview

$153.6k - $241.3k/yr

+ Short-term Incentives + Long-term Incentives

Senior

Boston, MA, USA

This position is currently classified as 'hybrid' in accordance with Takeda's Hybrid and Remote Work policy.

Category
General Marketing
Growth & Marketing
Required Skills
Market Research
Data Analysis
Requirements
  • Bachelor's degree in business, marketing, or related field; advanced degree
  • Minimum of 5 years of experience in brand insights, and field execution in the pharmaceutical industry
  • Matrix partner management experience
  • Experience implementing processes, procedures, market research and competitive intelligence in specialty biologics healthcare environment
  • Manage matrix teams, influencing outcomes in strategic and specific to marketing in specialty pharmaceuticals
Responsibilities
  • Responsible for providing insights and analytics thought partnership to support the development and execution of brand strategies, as well as executing field activities to drive brand awareness and sales.
  • Conduct brand and salesforce analytics in partnership with Brand Leads and Advanced Analytics team for US OBU franchises, including all brands in respective therapeutic areas.
  • Support and strengthen core analytics capabilities (targeting, segmentation, promotional analytics, market assessments, customer assessments, patient journey analytics etc.) to support brand strategy
  • Collaborate with brand IBT Leads and cross functional partners to maintain a comprehensive understanding of brand health, risks and opportunities through an integrated analytics synthesis
  • Lead a proactive and systematic approach to capturing and understanding brand needs for standard and ad-hoc analytics, reporting and insights generation
  • Develop and maintain brand key performance indicators (KPIs) and provide insights to brand teams
  • Plan and execute core analytics workstreams including targeting, segmentation, promotional analytics, Brand performance analytics, seamlessly integrating insights across workstreams
  • Partner with market research and CI team to identify customer needs, product awareness, positioning, messaging/effectiveness and competitive landscape
  • Stay up-to-date with industry trends and best practices in brand insights and analytics, as well as field execution strategies
  • Participate in the development and consolidation of KPI and business driving metrics in support of key brand review meetings
  • Collaborate with advanced analytics to expand insights on patient / customer journeys and predictive alerts
  • Develop and manage expectations, highlighting and resolving issues and ensuring regular communication of process enhancements
  • Deliver effective presentations of findings and recommendations to multiple levels of leadership, including the Head, US Insights & Analytics and US leadership team through various communication channels.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized in all operations.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene is worth up to $770 million.
  • The company is expanding its market presence in emerging Asian economies.
  • Takeda's focus on personalized medicine aligns with industry trends.

What critics are saying

  • Antitrust litigation over Amitiza could harm Takeda's reputation and finances.
  • A data breach incident poses significant cybersecurity and legal risks.
  • The telehealth market's rapid changes may affect Takeda's investment in American Well.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations.
  • Takeda has a robust pipeline with 11 NMEs and aims for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

ETF Daily News
May 11th, 2025
Tudor Investment Corp ET AL Decreases Stock Holdings in American Well Co. (NYSE:AMWL)

Takeda Pharmaceutical Co. Ltd. acquired a new stake in American Well in the fourth quarter worth about $564,000.

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.